摘要
1例肾癌伴发糖尿病患者在使用信迪利单抗后发生免疫相关性心肌炎。临床药师通过分析该患者心肌炎与信迪利单抗的关联性,结合循证证据提供合适的治疗方案,同时对患者进行了全程药学监护。最终患者免疫相关性心肌炎得到及时治疗,血糖控制在稳定范围。
A case of immune-associated myocarditis after using sindillizumab with renal cancer and diabetes was reported.By analyzing the association between the myocarditis and sindillizumab,based on the evidence-based evidence,clinical pharmacists provided appropriate treatment plan,and carried out pharmaceutical care for the patient the whole time.The patient received timely treatment for immune-associated myocarditis,and the blood glucose was controlled in a stable range.
作者
陈敏
张明伟
安薇
晏菲
Min CHEN;Ming-Wei ZHANG;Wei AN;Fei YAN(Department of Pharmacy,The Third People’s Hospital of Hubei Province,Wuhan 430033,China;Department of Oncology,The Third People’s Hospital of Hubei Province,Wuhan 430033,China)
出处
《药物流行病学杂志》
CAS
2023年第4期471-475,共5页
Chinese Journal of Pharmacoepidemiology
基金
湖北省卫生健康委员会科研项目(WJ2021F131)。